Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Biopsy route
1.1.2. End-use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Biopsy route outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Fusion Biopsy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of prostate cancer
3.4.1.2. Technological advancements in fusion imaging modalities
3.4.1.3. Increasing funds and investments by public and private sector
3.4.2. Market restraint analysis
3.4.2.1. High cost of fusion biopsy system
3.4.2.2. Liquid biopsy system
3.5. Fusion Biopsy Market Analysis Tools
3.5.1. Industry analysis – Porter’s Five Forces
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
3.5.5. COVID-19 Impact Analysis
Chapter 4. Fusion Biopsy Market: Biopsy Route Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Transrectal
4.1.2. Transperineal
4.2. Biopsy Route Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Fusion Biopsy Market by Biopsy Route Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Transrectal
4.5.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
4.5.2. Transperineal
4.5.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
Chapter 5. Fusion Biopsy Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Diagnostic centers
5.1.3. Ambulatory care centers
5.2. End-use Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Fusion Biopsy Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
5.5.2. Diagnostic centers
5.5.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
5.5.3. Ambulatory care centers
5.5.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
Chapter 6. Fusion Biopsy Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2022
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts and Trend Analysis, 2022 to 2030:
6.7. North America
6.7.1. U.S.
6.7.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.7.2. Canada
6.7.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8. Europe
6.8.1. UK
6.8.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.2. Germany
6.8.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.3. France
6.8.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.4. Italy
6.8.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.5. Spain
6.8.5.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.6. Denmark
6.8.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.7. Sweden
6.8.7.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.8. Norway
6.8.8.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9. Asia Pacific
6.9.1. Japan
6.9.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9.2. China
6.9.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9.3. India
6.9.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9.4. South Korea
6.9.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9.5. Thailand
6.9.5.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9.6. Australia
6.9.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.10. Latin America
6.10.1. Brazil
6.10.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.10.2. Mexico
6.10.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.10.3. Argentina
6.10.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.11. MEA
6.11.1. South Africa
6.11.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.11.2. Saudi Arabia
6.11.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.11.3. UAE
6.11.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.11.4. Kuwait
6.11.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competitive Categorization
7.2.1. Innovators
7.2.2. Market leaders
7.2.3. Emerging players
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2019
7.4. Public Companies
7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
7.4.2. Company market share/ranking, by region
7.4.3. Competitive dashboard analysis
7.4.3.1. Market differentiators
7.4.3.2. Synergy analysis: major deals and strategic alliances
7.5. Private Companies
7.5.1. List of key emerging companies/technology disruptors/innovators
7.5.2. Funding outlook
7.5.3. Regional network map
7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
7.5.5. Supplier ranking
7.5.6. Key company profiled
7.5.7. Eigen
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Koninklijke Philips N.V.
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Hitachi, Ltd.
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
7.5.10. MedCom
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Product benchmarking
7.5.10.4. Strategic initiatives
7.5.11. ESAOTE SPA
7.5.11.1. Company overview
7.5.11.2. Financial performance
7.5.11.3. Product benchmarking
7.5.11.4. Strategic initiatives
7.5.12. KOELIS
7.5.12.1. Company overview
7.5.12.2. Financial performance
7.5.12.3. Product benchmarking
7.5.12.4. Strategic initiatives
7.5.13. Focal Healthcare
7.5.13.1. Company overview
7.5.13.2. Financial performance
7.5.13.3. Product benchmarking
7.5.13.4. Strategic initiatives
7.5.14. GeoScan Medical
7.5.14.1. Company overview
7.5.14.2. Financial performance
7.5.14.3. Product benchmarking
7.5.14.4. Strategic initiatives
7.5.15. UC-Care Medical Systems Ltd.
7.5.15.1. Company overview
7.5.15.2. Financial performance
7.5.15.3. Product benchmarking
7.5.15.4. Strategic initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
